Advertisement

Professionally Responsible Counseling About Fetal Analysis

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Obstetrics and Gynecology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Screening for fetal chromosomal abnormalities: ACOG practice bulletin summary, number 226.
        Obstet Gynecol. 2020; 136: 859-867
        • American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics
        • Committee on Genetics; Society for Maternal-Fetal Medicine
        Screening for fetal chromosomal abnormalities: ACOG practice bulletin, number 226.
        Obstet Gynecol. 2020; 136: e48-e69
        • Chervenak F.A.
        • McCullough L.B.
        An ethically justified practical approach to offering, recommending, performing, and referring for induced abortion and feticide.
        Am J Obstet Gynecol. 2009; 560: e1-e6
        • Chervenak F.A.
        • McCullough L.B.
        Ethical dimensions of first-trimester fetal aneuploidy screening.
        Clin Obstet Gynecol. 2014; 57: 226-231
        • Nicolaides K.H.
        • Chervenak F.A.
        • McCullough L.B.
        • et al.
        Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21.
        Am J Obstet Gynecol. 2005; 193: 322-326
        • McCullough L.B.
        • Coverdale J.H.
        • Chervenak F.A.
        Professional ethics in obstetrics and gynecology.
        Cambridge University Press, Cambridge and New York2020
        • Chervenak F.A.
        • McCullough L.B.
        An ethically justified framework for clinical investigation to benefit pregnant and fetal patients.
        Am J Bioeth. 2011; : 1139-1149
        • Chervenak F.A.
        • McCullough L.B.
        • Brent R.L.
        The professional responsibility model of obstetrical ethics: avoiding the perils of clashing rights.
        Am J Obstet Gynecol. 2011; 205: 315.e1-315.e5
        • Chervenak F.A.
        • McCullough L.B.
        The unlimited-rights model of obstetric ethics threatens professionalism.
        BJOG. 2017; 124: 1144-1147
        • Chervenak F.A.
        • McCullough L.B.
        • Sharma G.
        • et al.
        Enhancing patient autonomy with risk assessment and invasive diagnosis: an ethical solution to a clinical challenge.
        Am J Obstet Gynecol. 2008; 199: 19.e1-19.e4
        • Scott Adzick N.
        • Thom E.A.
        • Spong C.Y.
        • et al.
        • for the MOMS Investigators
        A randomized trial of prenatal versus postnatal repair of myelomeningocele.
        N Engl J Med. 2011; 364: 993-1004
      2. U.S. Department of Health and Human Services. Office for Human Research Protections. 45 CFR 46. Available at: 45-CFR-46.HHS.gov, Accessed January 29, 2021.

        • Biffl W.L.
        • Spain D.A.
        • Reitsma A.M.
        • et al.
        • Society of University Surgeons Surgical Innovations Project Team
        Responsible development and application of surgical innovations: a position statement of the Society of University Surgeons.
        J Am Coll Surg. 2008; 206: 1204-1209
        • Moise Jr., K.J.
        • Johnson A.
        • Tsao K.
        Certification process of fetal centers in texas and developing national guidelines.
        Obstet Gynecol. 2020; 135: 141-147
      3. North American Fetal Therapy Network (NAFTNet). Available at: North American Fetal Therapy Network (NAFTNet) NAFTNet, Accessed January 29, 2021.

        • Collins F.S.
        • Doudna J.A.
        • Lander E.S.
        • et al.
        Human molecular genetics and genomics - important advances and exciting possibilities.
        N Engl J Med. 2021; 384: 1-4
        • Frangoul H.
        • Altshuler D.
        • Cappellini M.D.
        • et al.
        CRISPR-Cas9 gene editing for sickle cell disease and β-Thalassemia.
        N Engl J Med. 2021; 384: 252-260